81 research outputs found
Carbon and Climate Gaming
The issue of carbon use and possible associated climatic change has received growing attention in the last few years as an important aspect of assessing the impacts of various energy options. At IIASA that attention has been reflected in the Energy Systems Program and in the Global Climate Task of the Resources and Environment (REN) Area. As explained in this paper, the problem of climatic change can be viewed both as a problem of societal risk management and as a problem in strategic gaming behavior of the various decision makers involved. It is natural, then, that a joint working group at IIASA has formed, quite spontaneously, from representatives of the IIASA climate task (REN), the IIASA risk management project (Management and Technology Area, MMT), and the IIASA gaming project (MMT and Systems and Decision Sciences Area, SDS). This research group benefits from the multidisciplinary character of IIASA, which, along with its neutral scientific stance and long-standing interest in climate and energy, puts IIASA in an excellent position to increase our understanding of the problem of carbon use and climatic change. A list of IIASA papers and publications relating to climate is included here.
This paper describes an effort which began in March of 1980 and is expected to continue for another year or more. The paper consists primarily of material developed for a research proposal intended to assure continuation of the project. Two other working papers describing the project are also available. The paper entitled "An Interactive Model for Determining Coal Costs for a CO2-Game" (WP-80-154) describes in more detail the logic and a possible framework for parts of the proposed computer game. The paper "CO2: An Introduction and Possible Board Game" (WP-80-153) offers a non-technical sketch of the question and a description of the second proposed game. The development of the carbon and climate games described in these papers is being carried out at IIASA, while the actual gaming experiments are expected to take place both at IIASA and at other locations convenient for interested groups
Genome-wide association study identifies loci on 12q24 and 13q32 associated with Tetralogy of Fallot
We conducted a genome-wide association study to search for risk alleles associated with Tetralogy of Fallot (TOF), using a northern European discovery set of 835 cases and 5159 controls. A region on chromosome 12q24 was associated (P = 1.4 Ă 10â7) and replicated convincingly (P = 3.9 Ă 10â5) in 798 cases and 2931 controls [per allele odds ratio (OR) = 1.27 in replication cohort, P = 7.7 Ă 10â11 in combined populations]. Single nucleotide polymorphisms in the glypican 5 gene on chromosome 13q32 were also associated (P = 1.7 Ă 10â7) and replicated convincingly (P = 1.2 Ă 10â5) in 789 cases and 2927 controls (per allele OR = 1.31 in replication cohort, P = 3.03 Ă 10â11 in combined populations). Four additional regions on chromosomes 10, 15 and 16 showed suggestive association accompanied by nominal replication. This study, the first genome-wide association study of a congenital heart malformation phenotype, provides evidence that common genetic variation influences the risk of TO
Design and construction of the MicroBooNE detector
This paper describes the design and construction of the MicroBooNE liquid
argon time projection chamber and associated systems. MicroBooNE is the first
phase of the Short Baseline Neutrino program, located at Fermilab, and will
utilize the capabilities of liquid argon detectors to examine a rich assortment
of physics topics. In this document details of design specifications, assembly
procedures, and acceptance tests are reported
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes.
GWAS have identified >200 risk loci for Inflammatory Bowel Disease (IBD). The majority of disease associations are known to be driven by regulatory variants. To identify the putative causative genes that are perturbed by these variants, we generate a large transcriptome data set (nine disease-relevant cell types) and identify 23,650 cis-eQTL. We show that these are determined by âŒ9720 regulatory modules, of which âŒ3000 operate in multiple tissues and âŒ970 on multiple genes. We identify regulatory modules that drive the disease association for 63 of the 200 risk loci, and show that these are enriched in multigenic modules. Based on these analyses, we resequence 45 of the corresponding 100 candidate genes in 6600 Crohn disease (CD) cases and 5500 controls, and show with burden tests that they include likely causative genes. Our analyses indicate that â„10-fold larger sample sizes will be required to demonstrate the causality of individual genes using this approach
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk
Levels of circulating glucose are tightly regulated. To identify new loci influencing glycemic traits, we performed meta-analyses of 21 genome-wide association studies informative for fasting glucose, fasting insulin and indices of beta-cell function (HOMA-B) and insulin resistance (HOMA-IR) in up to 46,186 nondiabetic participants. Follow-up of 25 loci in up to 76,558 additional subjects identified 16 loci associated with fasting glucose and HOMA-B and two loci associated with fasting insulin and HOMA-IR. These include nine loci newly associated with fasting glucose (in or near ADCY5, MADD, ADRA2A, CRY2, FADS1, GLIS3, SLC2A2, PROX1 and C2CD4B) and one influencing fasting insulin and HOMA-IR (near IGF1). We also demonstrated association of ADCY5, PROX1, GCK, GCKR and DGKB-TMEM195 with type 2 diabetes. Within these loci, likely biological candidate genes influence signal transduction, cell proliferation, development, glucose-sensing and circadian regulation. Our results demonstrate that genetic studies of glycemic traits can identify type 2 diabetes risk loci, as well as loci containing gene variants that are associated with a modest elevation in glucose levels but are not associated with overt diabetes
Novel Loci for Adiponectin Levels and Their Influence on Type 2 Diabetes and Metabolic Traits : A Multi-Ethnic Meta-Analysis of 45,891 Individuals
J. Kaprio, S. Ripatti ja M.-L. Lokki työryhmien jÀseniÀ.Peer reviewe
Whole-genome sequencing reveals host factors underlying critical COVID-19
Critical COVID-19 is caused by immune-mediated inflammatory lung injury. Host genetic variation influences the development of illness requiring critical care1 or hospitalization2,3,4 after infection with SARS-CoV-2. The GenOMICC (Genetics of Mortality in Critical Care) study enables the comparison of genomes from individuals who are critically ill with those of population controls to find underlying disease mechanisms. Here we use whole-genome sequencing in 7,491 critically ill individuals compared with 48,400 controls to discover and replicate 23 independent variants that significantly predispose to critical COVID-19. We identify 16 new independent associations, including variants within genes that are involved in interferon signalling (IL10RB and PLSCR1), leucocyte differentiation (BCL11A) and blood-type antigen secretor status (FUT2). Using transcriptome-wide association and colocalization to infer the effect of gene expression on disease severity, we find evidence that implicates multiple genesâincluding reduced expression of a membrane flippase (ATP11A), and increased expression of a mucin (MUC1)âin critical disease. Mendelian randomization provides evidence in support of causal roles for myeloid cell adhesion molecules (SELE, ICAM5 and CD209) and the coagulation factor F8, all of which are potentially druggable targets. Our results are broadly consistent with a multi-component model of COVID-19 pathophysiology, in which at least two distinct mechanisms can predispose to life-threatening disease: failure to control viral replication; or an enhanced tendency towards pulmonary inflammation and intravascular coagulation. We show that comparison between cases of critical illness and population controls is highly efficient for the detection of therapeutically relevant mechanisms of disease
Plat book, city of Rochester, New York : carefully compiled from official records and surveys.
LeGear. Atlases of the United States, 5799Includes alphabetic list of street names.Stamped in blue ink on title page: Dutcher Brothers, 623 Powers Bldg. Rochester, N.Y. DL
The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy.
Contains fulltext :
51462.pdf (publisher's version ) (Closed access)Neutral lipid storage disease comprises a heterogeneous group of autosomal recessive disorders characterized by systemic accumulation of triglycerides in cytoplasmic droplets. Here we report a neutral lipid storage disease subgroup characterized by mild myopathy, absence of ichthyosis and mutations in both alleles of adipose triglyceride lipase (PNPLA2, also known as ATGL). Three of these mutations are predicted to lead to a truncated ATGL protein with an intact patatin domain containing the active site, but with defects in the hydrophobic domain. The block in triglyceride degradation was mimicked by short interfering RNA directed against ATGL. NLSDM is distinct from Chanarin-Dorfman syndrome, which is characterized by neutral lipid storage disease with ichthyosis, mild myopathy and hepatomegaly due to mutations in ABHD5 (also known as CGI-58)
- âŠ